Healthcare
Siemens Healthineers Shares Test Support After China Diagnostics Hit Sinks Earnings and Guidance
The structural breakdown in China’s diagnostics market has sent Siemens Healthineers shares spiralling to their weakest level in a year,...
BioNTech’s $650 Million R&D Quarter: Shareholders Back Board Expansion as Market Awaits Lung Cancer Data
Despite sitting on nearly $20 billion in cash, BioNTech is burning through money at an accelerating pace as it races...
Ocugen’s Gene Therapy Candidates Race Toward FDA Filings, But the Market Isn’t Ready to Celebrate
Ocugen is making quiet but meaningful progress across its pipeline of gene therapy programmes, yet the stock tells a more...
Ocugen Locks In Cash Runway to 2028 as Gene Therapy Platform Heads to Fort Lauderdale and Beyond
Ocugen has closed a $115 million convertible note offering that buys the biotech group more than two years of operating...
Novo Nordisk’s Teen Pill Win Offers a Rebound, But the Washington Game Is Shifting
Novo Nordisk’s shares staged a dramatic recovery on Friday, surging nearly 7% to close at €35.16, as investors seized on...
Siemens Healthineers Faces a Perfect Storm as Basel Conference Opens Against a Backdrop of Debt and Declining Shares
The irony could hardly be starker. As Siemens Healthineers kicks off the ECIO oncology conference in Basel today, showcasing the...
BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds
The rally in BioNTech shares this month has been one of the sector's standout stories, but a hefty insider sale...
Siemens Healthineers Hires a Google Brain Veteran as a 14 Billion Euro Debt Overhang Weighs on the Stock
Siemens Healthineers is charting an ambitious course into artificial intelligence while grappling with a punishing market environment that has driven...
Novo Nordisk’s Teen Pill Win Offers a Rebound, But the Payer Puzzle Remains Unsolved
Novo Nordisk closed the week with a 6.4% bounce to €35.09, its best single-day showing in months, after unveiling positive...
Siemens Healthineers Hits New Low as Spin-Off Timeline Firms Up and China Headwinds Deepen
Siemens Healthineers shares slumped to a fresh 52-week trough on Friday, touching €35.29, as the medical technology group prepares to...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
